Veronique Barban PhD

Veronique Barban is a trained Molecular and Cellular Virologist, with 30 years of experience in Vaccine Research in the Pharmaceutical Industry. She started her career as Research Scientist at Institut Merieux that later became Pasteur Merieux Connaught (PMC), then Sanofi Pasteur. She was Head for 20 years of a Virology group that worked on various human viral diseases and contributed 15 years to the development of the 1st dengue vaccine, licensed in 2015 (commercial name Dengvaxia). Her current position at Sanofi Pasteur is Expert in Virology in the Global Scientific Office.